|
Market Closed -
Nasdaq
20:00:00 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 5.070 USD | -1.55% |
|
+0.80% | -40.21% |
| 02:58am | Clinuvel Pharmaceuticals Seeks European Marketing Approvals for Neuracthel Instant Product | MT |
| 10-19 | Disc Medicine's late-stage win clears path for approval of sun-allergy pill | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,224B | |||||
| 662B | |||||
| 514B | |||||
| 388B | |||||
| 361B |
Select your edition
All financial news and data tailored to specific country editions
